CPL409116

· Celon Pharma SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPL409116, covering 2025-01-23 to 2025-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis [Phase 2]

See pricing